Harlan S. Robins, Chief Scientific Officer at Adaptive Biotechnologies Corp (ADPT), sold 64,424 shares at $18.61 ($1.2M) on 2025-12-03, disclosed to the SEC on 2025-12-05.
Scheduled sale ($1.2M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.61 | 27,212 | $506K | 43.0% |
| 2 | $18.61 | 27,212 | $506K | 43.0% |
| 3 | $16.61 | 10,000 | $166K | 14.1% |
| Total | $18.30 avg | 64,424 | $1.2M | 100% |
| Filing → |
| ADPT | SELL | 2026-06-17 | $1.8M | — | Filing → |
| ADPT | SELL | 2026-04-10 | $149K | — | Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |